Tigecycline: An investigational glycylcycline antimicrobialwith activity against resistant gram-positive organisms

Although published clinical trialsinvolving tigecycline are limited and additional trials are needed, preliminary reports on its use in the treatment of gram-positive infections are encouraging. Tigecycline has favorable pharmacokinetic properties and, apart from gastrointestinal adverse events, appears to be well tolerated.